
The weight-loss drug revolution
Business Daily
00:00
Developing a New Drug for Diabetes and Obesity
The chapter provides insights into the development process of CT388, a new drug intended to address type 2 diabetes and obesity, with potential broader applications and fewer side effects. The team discusses the multi-year timeline to bring the drug to market and their holistic approach to tackling complex metabolic issues.
Transcript
Play full episode